Cargando…

Outcomes in Brugada Syndrome Patients With Implantable Cardioverter-Defibrillators: Insights From the SGLT2 Registry

BACKGROUND AND OBJECTIVES: Brugada syndrome (BrS) is a cardiac ion channelopathy with characteristic electrocardiographic patterns, predisposing affected individuals to sudden cardiac death (SCD). Implantable cardioverter-defibrillator (ICD) is used for primary or secondary prevention in BrS, but it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Sharen, Li, Ka Hou Christien, Zhou, Jiandong, Leung, Keith Sai Kit, Lai, Rachel Wing Chuen, Li, Guoliang, Liu, Tong, Letsas, Konstantinos P., Mok, Ngai Shing, Zhang, Qingpeng, Tse, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076170/ https://www.ncbi.nlm.nih.gov/pubmed/32210841 http://dx.doi.org/10.3389/fphys.2020.00204

Ejemplares similares

Territory-wide cohort study of Brugada syndrome in Hong Kong: predictors of long-term outcomes using random survival forests and non-negative matrix factorisation
por: Lee, Sharen, et al.
Publicado: (2021)

Temporal Variability in Electrocardiographic Indices in Subjects With Brugada Patterns
por: Lee, Sharen, et al.
Publicado: (2020)

Identification of Novel SCN5A Single Nucleotide Variants in Brugada Syndrome: A Territory-Wide Study From Hong Kong
por: Tse, Gary, et al.
Publicado: (2020)

Risk stratification of sudden cardiac death in asymptomatic female Brugada syndrome patients: A literature review
por: Leung, Keith Sai Kit, et al.
Publicado: (2023)

Ventricular Tachyarrhythmia Risk in Paediatric/Young vs. Adult Brugada Syndrome Patients: A Territory-Wide Study
por: Lee, Sharen, et al.
Publicado: (2021)

Brugada syndrome: A comprehensive review of pathophysiological mechanisms and risk stratification strategies
por: Li, Ka Hou Christien, et al.
Publicado: (2020)

Prognosis after Implantation of Cardioverter-Defibrillators in Korean Patients with Brugada Syndrome
por: Son, Myoung Kyun, et al.
Publicado: (2014)

Implantable cardioverter‐defibrillator in Brugada syndrome: Long‐term follow‐up
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2019)

P-Wave Area Predicts New Onset Atrial Fibrillation in Mitral Stenosis: A Machine Learning Approach
por: Tse, Gary, et al.
Publicado: (2020)

Automated Electrocardiogram Analysis Identifies Novel Predictors of Ventricular Arrhythmias in Brugada Syndrome
por: Tse, Gary, et al.
Publicado: (2021)

Incorporating Latent Variables Using Nonnegative Matrix Factorization Improves Risk Stratification in Brugada Syndrome
por: Tse, Gary, et al.
Publicado: (2020)

Multi‐modality machine learning approach for risk stratification in heart failure with left ventricular ejection fraction ≤ 45%
por: Tse, Gary, et al.
Publicado: (2020)

General anaesthesia for insertion of an automated implantable cardioverter defibrillator in a child with Brugada and autism
por: Goraksha, Shwetal, et al.
Publicado: (2010)

Brugada Syndrome: The Role of Risk Stratification in Selecting Patients for Implantable Cardioverter-defibrillator Placement
por: Mankbadi, Michael, et al.
Publicado: (2018)

Inappropriate implantable cardioverter-defibrillator shocks in Brugada syndrome: Pattern in primary and secondary prevention
por: Bonny, Aimé, et al.
Publicado: (2016)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
por: Kawamura, Iwanari, et al.
Publicado: (2019)

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors vs. Dipeptidyl Peptidase-4 (DPP4) Inhibitors for New-Onset Dementia: A Propensity Score-Matched Population-Based Study With Competing Risk Analysis
por: Mui, Jonathan V., et al.
Publicado: (2021)

Paediatric/young versus adult patients with long QT syndrome
por: Lee, Sharen, et al.
Publicado: (2021)

Concomitant Brugada syndrome substrate ablation and epicardial abdominal cardioverter-defibrillator implantation in a child
por: de Asmundis, Carlo, et al.
Publicado: (2018)

Subcutaneous implantable cardioverter-defibrillator implantation assisted by hypnotic communication in a patient with Brugada syndrome
por: Scaglione, Marco, et al.
Publicado: (2019)

Low rates of liver injury in edoxaban users: Evidence from a territory‐wide observational cohort study
por: Zhou, Jiandong, et al.
Publicado: (2021)

Territory-Wide Chinese Cohort of Long QT Syndrome: Random Survival Forest and Cox Analyses
por: Tse, Gary, et al.
Publicado: (2021)

Development of a predictive risk model for all-cause mortality in patients with diabetes in Hong Kong
por: Lee, Sharen, et al.
Publicado: (2021)

A Case of Young Brugada Syndrome Patient With Implantable Cardioverter Defibrillator Complication Requiring Device Extraction and Reimplantation
por: Khan, Zahid
Publicado: (2023)

Implantable cardioverter-defibrillators /
Publicado: (1994)

T(peak)‐T(end), T(peak)‐T(end)/QT ratio and T(peak)‐T(end) dispersion for risk stratification in Brugada Syndrome: A systematic review and meta‐analysis
por: Tse, Gary, et al.
Publicado: (2018)

Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
por: Nakao, Yasuhisa, et al.
Publicado: (2020)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study
por: Zhou, Jiandong, et al.
Publicado: (2021)

Mid-term follow-up of patients with Brugada syndrome following a cardioverter defibrillator implantation: A single center experience
por: Kharazi, A, et al.
Publicado: (2007)

T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome
por: Kamakura, Tsukasa, et al.
Publicado: (2016)

Spontaneous type 1 pattern, ventricular arrhythmias and sudden cardiac death in Brugada Syndrome: an updated systematic review and meta-analysis
por: Bayoumy, Ahmed, et al.
Publicado: (2017)

Predictive value of neutrophil‐to‐lymphocyte ratio for atrial fibrillation and stroke in type 2 diabetes mellitus: The Hong Kong Diabetes Study
por: Chang, Carlin, et al.
Publicado: (2022)

The Gulf Implantable Cardioverter-defibrillator Registry: Rationale, Methodology, and Implementation
por: Alsheikh-Ali, Alawi A., et al.
Publicado: (2015)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Incident heart failure and myocardial infarction in sodium‐glucose cotransporter‐2 vs. dipeptidyl peptidase‐4 inhibitor users
por: Zhou, Jiandong, et al.
Publicado: (2022)

Measures of repolarization variability predict ventricular arrhythmogenesis in heptanol-treated Langendorff-perfused mouse hearts
por: Tse, Gary, et al.
Publicado: (2021)

Syncope and loss of consciousness after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: Prevalence and characteristics in long-term follow-up
por: Asada, Saori, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qtoh9mlefao4asc8u0dp8nb9kq